Cancer-Ibrutinib Intermedji

3-(4-Phenoxyphenyl)-1H-pirazolo[3,4-d]pirimidin-4-amine 330786-24-8

Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Farmaċewtika Industrijali |Mediċini kontra t-tumur |Ibrutinib Intermedji |3-(4-Fenossifenil)-1H-pirazolo[3,4-d]pirimidin-4-amina |CAS:330786-24-8 |C17H13N5O

inkjesta dettall
3-Amino-4-cyano-5-(4-phenoxyphenyl)pirazol 330792-70-6

Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Farmaċewtika Industrijali |Mediċini kontra t-tumur |Ibrutinib Intermedji |3-Amino-4-cyano-5-(4-phenoxyphenyl)pirazol |CAS: 330792-70-6|C16H12N4O

inkjesta dettall
1-Boc-3-hydroxypiperidine 85275-45-2

Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Farmaċewtika Industrijali |Mediċini kontra t-tumur |Ibrutinib Intermedji |1-Boc-3-hydroxypiperidine |CAS:85275-45-2 |C10H19NO3

inkjesta dettall
(S)-1-Boc-3-hydroxypiperidine 143900-44-1

Manifattura professjonali u provvista bijofarmaċewtika |Materja Prima |Reaġenti Farmaċewtiċi Intermedji |Farmaċewtika Industrijali |Mediċini kontra t-tumur |Ibrutinib Intermedji |(S)-1-Boc-3-hydroxypiperidine |CAS:143900-44-1 |C10H19NO3

inkjesta dettall